APO Research
Talk to an analyst

APO RESEARCH · REPORT

Carina Endobronchial Blocker

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Carina Endobronchial Blocker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025199 pages

Choose your research edition.

Industry ResearchCarina Endobronchial Blocker Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Carina Endobronchial Blocker Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Carina Endobronchial Blocker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carina Endobronchial Blocker Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Carina Endobronchial Blocker Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Carina Endobronchial Blocker market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Carina Endobronchial Blocker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Carina Endobronchial Blocker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carina Endobronchial Blocker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Carina Endobronchial Blocker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Carina Endobronchial Blocker include Orcl MEDICAL Company, MoNi Medical Technology, Well Lead Medical, Vygon, Truphatek International, Teleflex, SUMI, Stryker and P3 Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Carina Endobronchial Blocker market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Carina Endobronchial Blocker and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Carina Endobronchial Blocker sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Carina Endobronchial Blocker market size, projected growth trends, production technologies, key applications, and end-use industries.

Carina Endobronchial Blocker Segment by Company

Orcl MEDICAL Company

MoNi Medical Technology

Well Lead Medical

Vygon

Truphatek International

Teleflex

SUMI

Stryker

P3 Medical

Olympus Medical

Merit Medical

Cook Medical

Broncus Medical

Boston Scientific

AMK Medical

Ambu

Carina Endobronchial Blocker Segment by Type

Visualization

Non-Visualization

Carina Endobronchial Blocker Segment by Application

Treatment of Lung Diseases

Pulmonary Function Test

Thoracic Surgery

Other

Carina Endobronchial Blocker Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carina Endobronchial Blocker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carina Endobronchial Blocker and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carina Endobronchial Blocker.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Carina Endobronchial Blocker market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Carina Endobronchial Blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Carina Endobronchial Blocker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Carina Endobronchial Blocker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Carina Endobronchial Blocker Industry Trends Table 2. Carina Endobronchial Blocker Industry Drivers Table 3. Carina Endobronchial Blocker Industry Opportunities and Challenges Table 4. Carina Endobronchial Blocker Industry Restraints Table 5. Global Carina Endobronchial Blocker Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Carina Endobronchial Blocker Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Carina Endobronchial Blocker Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Carina Endobronchial Blocker Sales Market Share by Manufacturers Table 9. Global Carina Endobronchial Blocker Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Carina Endobronchial Blocker Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Carina Endobronchial Blocker Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Carina Endobronchial Blocker Manufacturers, Product Type & Application Table 13. Global Carina Endobronchial Blocker Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Carina Endobronchial Blocker by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Visualization Table 17. Major Manufacturers of Non-Visualization Table 18. Global Carina Endobronchial Blocker Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Carina Endobronchial Blocker Sales by Type (2021-2026) & (K Units) Table 20. Global Carina Endobronchial Blocker Sales by Type (2027-2032) & (K Units) Table 21. Global Carina Endobronchial Blocker Sales Market Share by Type (2021-2026) Table 22. Global Carina Endobronchial Blocker Sales Market Share by Type (2027-2032) Table 23. Global Carina Endobronchial Blocker Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Carina Endobronchial Blocker Revenue by Type (2021-2026) & (K Units) Table 25. Global Carina Endobronchial Blocker Revenue by Type (2027-2032) & (K Units) Table 26. Global Carina Endobronchial Blocker Revenue Market Share by Type (2021-2026) Table 27. Global Carina Endobronchial Blocker Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Treatment of Lung Diseases Table 29. Major Manufacturers of Pulmonary Function Test Table 30. Major Manufacturers of Thoracic Surgery Table 31. Major Manufacturers of Other Table 32. Global Carina Endobronchial Blocker Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Carina Endobronchial Blocker Sales by Application (2021-2026) & (K Units) Table 34. Global Carina Endobronchial Blocker Sales by Application (2027-2032) & (K Units) Table 35. Global Carina Endobronchial Blocker Sales Market Share by Application (2021-2026) Table 36. Global Carina Endobronchial Blocker Sales Market Share by Application (2027-2032) Table 37. Global Carina Endobronchial Blocker Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Carina Endobronchial Blocker Revenue by Application (2021-2026) & (K Units) Table 39. Global Carina Endobronchial Blocker Revenue by Application (2027-2032) & (K Units) Table 40. Global Carina Endobronchial Blocker Revenue Market Share by Application (2021-2026) Table 41. Global Carina Endobronchial Blocker Revenue Market Share by Application (2027-2032) Table 42. Global Carina Endobronchial Blocker Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Carina Endobronchial Blocker Sales by Region (2021-2026) & (K Units) Table 44. Global Carina Endobronchial Blocker Sales Market Share by Region (2021-2026) Table 45. Global Carina Endobronchial Blocker Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Carina Endobronchial Blocker Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Carina Endobronchial Blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Carina Endobronchial Blocker Sales by Country (2021-2026) & (K Units) Table 49. North America Carina Endobronchial Blocker Sales by Country (2027-2032) & (K Units) Table 50. Europe Carina Endobronchial Blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Carina Endobronchial Blocker Sales by Country (2021-2026) & (K Units) Table 52. Europe Carina Endobronchial Blocker Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Carina Endobronchial Blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Carina Endobronchial Blocker Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Carina Endobronchial Blocker Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Carina Endobronchial Blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Carina Endobronchial Blocker Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Carina Endobronchial Blocker Sales by Country (2027-2032) & (K Units) Table 59. Global Carina Endobronchial Blocker Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Carina Endobronchial Blocker Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Carina Endobronchial Blocker Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Carina Endobronchial Blocker Revenue Market Share by Region (2021-2026) Table 63. Global Carina Endobronchial Blocker Revenue Market Share by Region (2027-2032) Table 64. Orcl MEDICAL Company Company Information Table 65. Orcl MEDICAL Company Business Overview Table 66. Orcl MEDICAL Company Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Orcl MEDICAL Company Carina Endobronchial Blocker Product Portfolio Table 68. Orcl MEDICAL Company Recent Development Table 69. MoNi Medical Technology Company Information Table 70. MoNi Medical Technology Business Overview Table 71. MoNi Medical Technology Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. MoNi Medical Technology Carina Endobronchial Blocker Product Portfolio Table 73. MoNi Medical Technology Recent Development Table 74. Well Lead Medical Company Information Table 75. Well Lead Medical Business Overview Table 76. Well Lead Medical Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Well Lead Medical Carina Endobronchial Blocker Product Portfolio Table 78. Well Lead Medical Recent Development Table 79. Vygon Company Information Table 80. Vygon Business Overview Table 81. Vygon Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Vygon Carina Endobronchial Blocker Product Portfolio Table 83. Vygon Recent Development Table 84. Truphatek International Company Information Table 85. Truphatek International Business Overview Table 86. Truphatek International Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Truphatek International Carina Endobronchial Blocker Product Portfolio Table 88. Truphatek International Recent Development Table 89. Teleflex Company Information Table 90. Teleflex Business Overview Table 91. Teleflex Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Teleflex Carina Endobronchial Blocker Product Portfolio Table 93. Teleflex Recent Development Table 94. SUMI Company Information Table 95. SUMI Business Overview Table 96. SUMI Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. SUMI Carina Endobronchial Blocker Product Portfolio Table 98. SUMI Recent Development Table 99. Stryker Company Information Table 100. Stryker Business Overview Table 101. Stryker Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Stryker Carina Endobronchial Blocker Product Portfolio Table 103. Stryker Recent Development Table 104. P3 Medical Company Information Table 105. P3 Medical Business Overview Table 106. P3 Medical Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. P3 Medical Carina Endobronchial Blocker Product Portfolio Table 108. P3 Medical Recent Development Table 109. Olympus Medical Company Information Table 110. Olympus Medical Business Overview Table 111. Olympus Medical Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Olympus Medical Carina Endobronchial Blocker Product Portfolio Table 113. Olympus Medical Recent Development Table 114. Merit Medical Company Information Table 115. Merit Medical Business Overview Table 116. Merit Medical Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Merit Medical Carina Endobronchial Blocker Product Portfolio Table 118. Merit Medical Recent Development Table 119. Cook Medical Company Information Table 120. Cook Medical Business Overview Table 121. Cook Medical Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Cook Medical Carina Endobronchial Blocker Product Portfolio Table 123. Cook Medical Recent Development Table 124. Broncus Medical Company Information Table 125. Broncus Medical Business Overview Table 126. Broncus Medical Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Broncus Medical Carina Endobronchial Blocker Product Portfolio Table 128. Broncus Medical Recent Development Table 129. Boston Scientific Company Information Table 130. Boston Scientific Business Overview Table 131. Boston Scientific Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Boston Scientific Carina Endobronchial Blocker Product Portfolio Table 133. Boston Scientific Recent Development Table 134. AMK Medical Company Information Table 135. AMK Medical Business Overview Table 136. AMK Medical Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. AMK Medical Carina Endobronchial Blocker Product Portfolio Table 138. AMK Medical Recent Development Table 139. Ambu Company Information Table 140. Ambu Business Overview Table 141. Ambu Carina Endobronchial Blocker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Ambu Carina Endobronchial Blocker Product Portfolio Table 143. Ambu Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Carina Endobronchial Blocker Distributors List Table 147. Carina Endobronchial Blocker Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Carina Endobronchial Blocker Product Image Figure 2. Global Carina Endobronchial Blocker Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carina Endobronchial Blocker Market Size (2021-2032) & (US$ Million) Figure 4. Global Carina Endobronchial Blocker Sales (2021-2032) & (K Units) Figure 5. Global Carina Endobronchial Blocker Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Carina Endobronchial Blocker Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Visualization Image Figure 9. Non-Visualization Image Figure 10. Global Carina Endobronchial Blocker Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Carina Endobronchial Blocker Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Carina Endobronchial Blocker Sales Market Share by Type (2021-2032) Figure 13. Global Carina Endobronchial Blocker Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Carina Endobronchial Blocker Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Carina Endobronchial Blocker Revenue Market Share by Type (2021-2032) Figure 16. Treatment of Lung Diseases Image Figure 17. Pulmonary Function Test Image Figure 18. Thoracic Surgery Image Figure 19. Other Image Figure 20. Global Carina Endobronchial Blocker Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Carina Endobronchial Blocker Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Carina Endobronchial Blocker Sales Market Share by Application (2021-2032) Figure 23. Global Carina Endobronchial Blocker Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Carina Endobronchial Blocker Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Carina Endobronchial Blocker Revenue Market Share by Application (2021-2032) Figure 26. North America Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Carina Endobronchial Blocker Sales Market Share by Country (2021-2032) Figure 28. U.S. Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Carina Endobronchial Blocker Sales Market Share by Country (2021-2032) Figure 33. Germany Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Carina Endobronchial Blocker Sales Market Share by Country (2021-2032) Figure 40. China Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Carina Endobronchial Blocker Sales Market Share by Country (2021-2032) Figure 48. Brazil Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Carina Endobronchial Blocker Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Carina Endobronchial Blocker Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Carina Endobronchial Blocker Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Carina Endobronchial Blocker Revenue (2021-2032) & (US$ Million) Figure 59. North America Carina Endobronchial Blocker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Carina Endobronchial Blocker Revenue (2021-2032) & (US$ Million) Figure 61. Europe Carina Endobronchial Blocker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Carina Endobronchial Blocker Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Carina Endobronchial Blocker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Carina Endobronchial Blocker Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Carina Endobronchial Blocker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Carina Endobronchial Blocker Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Carina Endobronchial Blocker Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Visualization
  • Non-Visualization
Applications
  • Treatment of Lung Diseases
  • Pulmonary Function Test
  • Thoracic Surgery
  • Other
Companies covered
  • Orcl MEDICAL Company
  • MoNi Medical Technology
  • Well Lead Medical
  • Vygon
  • Truphatek International
  • Teleflex
  • SUMI
  • Stryker
  • P3 Medical
  • Olympus Medical
  • Merit Medical
  • Cook Medical
  • Broncus Medical
  • Boston Scientific
  • AMK Medical
  • Ambu

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Carina Endobronchial Blocker Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Carina Endobronchial Blocker Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Carina Endobronchial Blocker Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Carina Endobronchial Blocker Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Carina Endobronchial Blocker Market Dynamics
  1. 2.1 Carina Endobronchial Blocker Industry Trends
  2. 2.2 Carina Endobronchial Blocker Industry Drivers
  3. 2.3 Carina Endobronchial Blocker Industry Opportunities and Challenges
  4. 2.4 Carina Endobronchial Blocker Industry Restraints
3 Carina Endobronchial Blocker Market by Manufacturers
  1. 3.1 Global Carina Endobronchial Blocker Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Carina Endobronchial Blocker Sales by Manufacturers (2021-2026)
  3. 3.3 Global Carina Endobronchial Blocker Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Carina Endobronchial Blocker Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Carina Endobronchial Blocker Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Carina Endobronchial Blocker Manufacturers, Product Type & Application
  7. 3.7 Global Carina Endobronchial Blocker Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Carina Endobronchial Blocker Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Carina Endobronchial Blocker Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Carina Endobronchial Blocker Tier 1, Tier 2, and Tier 3
4 Carina Endobronchial Blocker Market by Type
  1. 4.1 Carina Endobronchial Blocker Type Introduction
  2. 4.1.1 Visualization
  3. 4.1.2 Non-Visualization
  4. 4.2 Global Carina Endobronchial Blocker Sales by Type
  5. 4.2.1 Global Carina Endobronchial Blocker Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Carina Endobronchial Blocker Sales by Type (2021-2032)
  7. 4.2.3 Global Carina Endobronchial Blocker Sales Market Share by Type (2021-2032)
  8. 4.3 Global Carina Endobronchial Blocker Revenue by Type
  9. 4.3.1 Global Carina Endobronchial Blocker Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Carina Endobronchial Blocker Revenue by Type (2021-2032)
  11. 4.3.3 Global Carina Endobronchial Blocker Revenue Market Share by Type (2021-2032)
5 Carina Endobronchial Blocker Market by Application
  1. 5.1 Carina Endobronchial Blocker Application Introduction
  2. 5.1.1 Treatment of Lung Diseases
  3. 5.1.2 Pulmonary Function Test
  4. 5.1.3 Thoracic Surgery
  5. 5.1.4 Other
  6. 5.2 Global Carina Endobronchial Blocker Sales by Application
  7. 5.2.1 Global Carina Endobronchial Blocker Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Carina Endobronchial Blocker Sales by Application (2021-2032)
  9. 5.2.3 Global Carina Endobronchial Blocker Sales Market Share by Application (2021-2032)
  10. 5.3 Global Carina Endobronchial Blocker Revenue by Application
  11. 5.3.1 Global Carina Endobronchial Blocker Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Carina Endobronchial Blocker Revenue by Application (2021-2032)
  13. 5.3.3 Global Carina Endobronchial Blocker Revenue Market Share by Application (2021-2032)
6 Global Carina Endobronchial Blocker Sales by Region
  1. 6.1 Global Carina Endobronchial Blocker Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Carina Endobronchial Blocker Sales by Region (2021-2032)
  3. 6.2.1 Global Carina Endobronchial Blocker Sales by Region (2021-2026)
  4. 6.2.2 Global Carina Endobronchial Blocker Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Carina Endobronchial Blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Carina Endobronchial Blocker Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Carina Endobronchial Blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Carina Endobronchial Blocker Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Carina Endobronchial Blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Carina Endobronchial Blocker Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Carina Endobronchial Blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Carina Endobronchial Blocker Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Carina Endobronchial Blocker Revenue by Region
  1. 7.1 Global Carina Endobronchial Blocker Revenue by Region
  2. 7.1.1 Global Carina Endobronchial Blocker Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Carina Endobronchial Blocker Revenue by Region (2021-2026)
  4. 7.1.3 Global Carina Endobronchial Blocker Revenue by Region (2027-2032)
  5. 7.1.4 Global Carina Endobronchial Blocker Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Carina Endobronchial Blocker Revenue (2021-2032)
  8. 7.2.2 North America Carina Endobronchial Blocker Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Carina Endobronchial Blocker Revenue (2021-2032)
  11. 7.3.2 Europe Carina Endobronchial Blocker Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Carina Endobronchial Blocker Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Carina Endobronchial Blocker Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Carina Endobronchial Blocker Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Carina Endobronchial Blocker Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Orcl MEDICAL Company
  2. 8.1.1 Orcl MEDICAL Company Company Information
  3. 8.1.2 Orcl MEDICAL Company Business Overview
  4. 8.1.3 Orcl MEDICAL Company Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Orcl MEDICAL Company Carina Endobronchial Blocker Product Portfolio
  6. 8.1.5 Orcl MEDICAL Company Recent Developments
  7. 8.2 MoNi Medical Technology
  8. 8.2.1 MoNi Medical Technology Company Information
  9. 8.2.2 MoNi Medical Technology Business Overview
  10. 8.2.3 MoNi Medical Technology Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MoNi Medical Technology Carina Endobronchial Blocker Product Portfolio
  12. 8.2.5 MoNi Medical Technology Recent Developments
  13. 8.3 Well Lead Medical
  14. 8.3.1 Well Lead Medical Company Information
  15. 8.3.2 Well Lead Medical Business Overview
  16. 8.3.3 Well Lead Medical Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Well Lead Medical Carina Endobronchial Blocker Product Portfolio
  18. 8.3.5 Well Lead Medical Recent Developments
  19. 8.4 Vygon
  20. 8.4.1 Vygon Company Information
  21. 8.4.2 Vygon Business Overview
  22. 8.4.3 Vygon Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vygon Carina Endobronchial Blocker Product Portfolio
  24. 8.4.5 Vygon Recent Developments
  25. 8.5 Truphatek International
  26. 8.5.1 Truphatek International Company Information
  27. 8.5.2 Truphatek International Business Overview
  28. 8.5.3 Truphatek International Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Truphatek International Carina Endobronchial Blocker Product Portfolio
  30. 8.5.5 Truphatek International Recent Developments
  31. 8.6 Teleflex
  32. 8.6.1 Teleflex Company Information
  33. 8.6.2 Teleflex Business Overview
  34. 8.6.3 Teleflex Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teleflex Carina Endobronchial Blocker Product Portfolio
  36. 8.6.5 Teleflex Recent Developments
  37. 8.7 SUMI
  38. 8.7.1 SUMI Company Information
  39. 8.7.2 SUMI Business Overview
  40. 8.7.3 SUMI Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SUMI Carina Endobronchial Blocker Product Portfolio
  42. 8.7.5 SUMI Recent Developments
  43. 8.8 Stryker
  44. 8.8.1 Stryker Company Information
  45. 8.8.2 Stryker Business Overview
  46. 8.8.3 Stryker Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Stryker Carina Endobronchial Blocker Product Portfolio
  48. 8.8.5 Stryker Recent Developments
  49. 8.9 P3 Medical
  50. 8.9.1 P3 Medical Company Information
  51. 8.9.2 P3 Medical Business Overview
  52. 8.9.3 P3 Medical Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 P3 Medical Carina Endobronchial Blocker Product Portfolio
  54. 8.9.5 P3 Medical Recent Developments
  55. 8.10 Olympus Medical
  56. 8.10.1 Olympus Medical Company Information
  57. 8.10.2 Olympus Medical Business Overview
  58. 8.10.3 Olympus Medical Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Olympus Medical Carina Endobronchial Blocker Product Portfolio
  60. 8.10.5 Olympus Medical Recent Developments
  61. 8.11 Merit Medical
  62. 8.11.1 Merit Medical Company Information
  63. 8.11.2 Merit Medical Business Overview
  64. 8.11.3 Merit Medical Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Merit Medical Carina Endobronchial Blocker Product Portfolio
  66. 8.11.5 Merit Medical Recent Developments
  67. 8.12 Cook Medical
  68. 8.12.1 Cook Medical Company Information
  69. 8.12.2 Cook Medical Business Overview
  70. 8.12.3 Cook Medical Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cook Medical Carina Endobronchial Blocker Product Portfolio
  72. 8.12.5 Cook Medical Recent Developments
  73. 8.13 Broncus Medical
  74. 8.13.1 Broncus Medical Company Information
  75. 8.13.2 Broncus Medical Business Overview
  76. 8.13.3 Broncus Medical Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Broncus Medical Carina Endobronchial Blocker Product Portfolio
  78. 8.13.5 Broncus Medical Recent Developments
  79. 8.14 Boston Scientific
  80. 8.14.1 Boston Scientific Company Information
  81. 8.14.2 Boston Scientific Business Overview
  82. 8.14.3 Boston Scientific Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boston Scientific Carina Endobronchial Blocker Product Portfolio
  84. 8.14.5 Boston Scientific Recent Developments
  85. 8.15 AMK Medical
  86. 8.15.1 AMK Medical Company Information
  87. 8.15.2 AMK Medical Business Overview
  88. 8.15.3 AMK Medical Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AMK Medical Carina Endobronchial Blocker Product Portfolio
  90. 8.15.5 AMK Medical Recent Developments
  91. 8.16 Ambu
  92. 8.16.1 Ambu Company Information
  93. 8.16.2 Ambu Business Overview
  94. 8.16.3 Ambu Carina Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Ambu Carina Endobronchial Blocker Product Portfolio
  96. 8.16.5 Ambu Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Carina Endobronchial Blocker Value Chain Analysis
  2. 9.1.1 Carina Endobronchial Blocker Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Carina Endobronchial Blocker Production Mode & Process
  6. 9.2 Carina Endobronchial Blocker Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Carina Endobronchial Blocker Distributors
  9. 9.2.3 Carina Endobronchial Blocker Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst